Trade SLS anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
SELLAS Life Sciences Group, Inc. (SLS) is trading at US$15.21, up 10.78% today as of Aug 27, 16:00 EDT. The company has a market capitalisation of US$3.12B. Over the past 52 weeks, SLS has traded between US$1.39 and US$15.88. On Syfe you can trade SLS with $0 commission and add it to your watchlist.
| Previous close | US$13.73 |
|---|---|
| Market cap | US$3.12B |
| 52-week range | US$1.39 – US$15.88 |
| Volume | 11.98M |
| Exchange | US |
Add to Watchlist
Set Price Alert
SELLAS Life Sciences Group, Inc.
SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.
Year: 2008
Social Buzz: Wallstreetbets Stocks Advance Premarket Monday; SELLAS Life Sciences, Strategy to Open Higher
Jun 29, 10:40 AM · MT Newswires
SELLAS Life Sciences Group Q1 Loss Narrows
May 12, 8:44 PM · MT Newswires
SELLAS Life Sciences Group, Inc. (SLS) stock is trading at US$15.21, +10.78% from the previous close of US$13.73.
The market cap for SELLAS Life Sciences Group, Inc. (SLS) stock is approximately US$3.12B.
The 52-week high for SELLAS Life Sciences Group, Inc. (SLS) stock is US$15.88.
The 52-week low for SELLAS Life Sciences Group, Inc. (SLS) stock is US$1.39.
SELLAS Life Sciences Group, Inc. (SLS) does not currently pay a dividend.
Stay on top of SLS
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
